POINT BIOPHARMA GLOBAL INC (PNT) Earnings History & Surprises

NASDAQ:PNT • US7305411099

Current stock price

12.5 USD
+0.02 (+0.16%)
At close:
12.51 USD
+0.01 (+0.08%)
After Hours:

PNT Earnings overview

Past quarterly earnings results for POINT BIOPHARMA GLOBAL INC (PNT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Mar 22, 2024
Period
Q4 / 2023
EPS Estimate
-$0.26
Revenue Estimate
2.289M

Last Reported

Most Recent
Release Date
Nov 13, 2023
Period
Q3 / 2023
EPS Reported
-$0.23
EPS Surprise
24.55%
Revenue Surprise
211.88%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2023 -0.23 -0.30 24.55% 11.54% 2.8M 897.779K 211.88% -
Q2 2023 -0.24 -0.30 19.08% 11.11% 4.9M 953.884K 413.69% -
Q1 2023 -0.16 -0.32 49.55% 11.11% 9.5M - -
Q4 2022 -0.26 - -65.53% 226.6M 26.26M 762.91% -
Q3 2022 -0.26 -0.29 8.79% -36.84% - -
Q2 2022 -0.27 -0.22 -20.42% -80.00% - -
Q1 2022 -0.18 -0.21 15.13% - - -
Q4 2021 -0.16 -0.24 32.59% - - -
Q3 2021 -0.19 -0.19 -0.78% - - -
Q2 2021 -0.15 -0.11 -35.01% - - -
Q1 2021 - - - -
Q4 2020 - - - -
Q3 2020 - - - -
Q2 2020 - - - -
Q1 2020 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

PNT EPS Q2Q GrowthPNT EPS Q2Q GrowthEPS Q2Q Growth Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Q3/26 0 500 1K 1.5K 2K

Revenue Historical Q2Q growth and Acceleration

PNT Revenue Q2Q GrowthPNT Revenue Q2Q GrowthRevenue Q2Q Growth Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Q3/26 0 5K 10K 15K 20K 25K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

PNT Overview PNT Technical Analysis Report PNT Fundamental Analysis Report PNT Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

POINT BIOPHARMA GLOBAL INC / PNT Earnings FAQ

When did POINT BIOPHARMA GLOBAL INC (PNT) report earnings last quarter?

POINT BIOPHARMA GLOBAL INC (PNT) last reported earnings on 11/13/2023.

Can you provide information on whether POINT BIOPHARMA GLOBAL INC beat earnings estimates in the last quarter?

POINT BIOPHARMA GLOBAL INC (PNT) beat EPS estimates and beat revenue estimates in the most recent quarter.